EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial

Rong Fan, Rui Deng, Qing Xie, Fang Wang, Xieer Liang, Hong Ma, Huiying Rao, Yanhang Gao, Chunxiu Zhong, Qing Guo, Sheng Shen, Ya Xu und 5 weitere

Clinical Gastroenterology and Hepatology · 2026-06 · 24 (6) · 1611-1620

DOI: 10.1016/j.cgh.2025.09.009 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-06. Verfasst von Rong Fan und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Multi-organ Injury Prevention and Treatment, Key Laboratory of Infectious Diseases Research in South China, Ministry of Educa…. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B, Chronic, Antiviral Agents, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Nucleos(t)ide analogue (NAs) discontinuation promotes hepatitis B surface antigen (HBsAg) clearance among European patients with chronic hepatitis B virus (HBV) infection. The efficacy and safety of a novel HBV biomarker-guided NAs withdrawal strategy among Asian patients was evaluated in this multicenter randomized controlled trial. METHODS: NAs-experienced patients achieving HBsAg

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHepatitis B, ChronicAntiviral AgentsBiomarkersWithholding TreatmentHumansMaleMiddle AgedFemaleAdultHepatitis B virusDNA, ViralAsian PeopleTreatment Outcome

Stichwörter der Autor:innen

Chronic Hepatitis BHBV BiomarkerHepatitis B Surface Antigen LossNucleos(t)ide AnaloguesTreatment Discontinuation

Substanzen

Hepatitis B Surface AntigensAntiviral AgentsBiomarkersDNA, Viral

Autor:innen und Institutionen

  • State Key Laboratory of Multi-organ Injury Prevention and Treatment, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory for Prevention and Control o…
  • Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Hepatology, Shenzhen Third People's Hospital, National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Sh…
  • Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Peking University Hepatology Institute, Peking University People's Hospital, Beijing, China.
  • Department of Hepatology, The First Hospital of Jilin University, Jilin University, Changchun, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Fan, R., Deng, R., Xie, Q., Wang, F., Liang, X., Ma, H., Rao, H., Gao, Y., Zhong, C., Guo, Q., Shen, S., Xu, Y., Lu, X., Gao, H., Bai, H., Dou, X., & Sun, J. (2026). Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 24(6), 1611-1620. https://doi.org/10.1016/j.cgh.2025.09.009

Vancouver

Fan R, Deng R, Xie Q, Wang F, Liang X, Ma H, et al. Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 2026;24(6):1611-1620. doi:10.1016/j.cgh.2025.09.009

BibTeX
@article{Fan2026,
  author = {Fan, Rong and Deng, Rui and Xie, Qing and Wang, Fang and Liang, Xieer and Ma, Hong and Rao, Huiying and Gao, Yanhang and Zhong, Chunxiu and Guo, Qing and Shen, Sheng and Xu, Ya and Lu, Xingyu and Gao, Hongbo and Bai, Honglian and Dou, Xiaoguang and Sun, Jian},
  title = {Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {6},
  pages = {1611--1620},
  doi = {10.1016/j.cgh.2025.09.009}
}
Kostenlos starten →